Literature DB >> 15290352

The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article.

A Lamberti1, M Caraglia, O Longo, M Marra, A Abbruzzese, P Arcari.   

Abstract

An increasing number of evidences suggest the involvement of the eukaryotic elongation factor 1A, a core component of the protein synthesis machinery, at the onset of cell transformation. In fact, eEF1A is shown to be up-regulated in cell death; moreover, it seems to be involved in the regulation of ubiquitin-mediated protein degradation. In addition, eEF1A undergoes several post-translational modifications, mainly phosphorylation and methylation, that generally influence the activity of the protein. This article summarizes the present knowledges on the several extra-translational roles of eEF1A also in order to understand as the protein synthesis regulatory mechanisms could offer tools for cancer intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290352     DOI: 10.1007/s00726-004-0088-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  50 in total

1.  eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser⁵³ is a novel substrate for protein kinase C βI.

Authors:  Manuela Piazzi; Alberto Bavelloni; Irene Faenza; William Blalock; Andrea Urbani; Simona D'Aguanno; Roberta Fiume; Giulia Ramazzotti; Nadir Mario Maraldi; Lucio Cocco
Journal:  Mol Cell Proteomics       Date:  2010-10-05       Impact factor: 5.911

2.  Ribosomal slowdown mediates translational arrest during cellular division.

Authors:  Gilad Sivan; Nancy Kedersha; Orna Elroy-Stein
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

3.  Improper organization of the actin cytoskeleton affects protein synthesis at initiation.

Authors:  Stephane R Gross; Terri Goss Kinzy
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

4.  Evidence that eukaryotic translation elongation factor 1A (eEF1A) binds the Gcn2 protein C terminus and inhibits Gcn2 activity.

Authors:  Jyothsna Visweswaraiah; Sebastien Lageix; Beatriz A Castilho; Lara Izotova; Terri Goss Kinzy; Alan G Hinnebusch; Evelyn Sattlegger
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

5.  Protein interactions, post-translational modifications and topologies in human cells.

Authors:  Juan D Chavez; Chad R Weisbrod; Chunxiang Zheng; Jimmy K Eng; James E Bruce
Journal:  Mol Cell Proteomics       Date:  2013-01-25       Impact factor: 5.911

6.  METTL21B Is a Novel Human Lysine Methyltransferase of Translation Elongation Factor 1A: Discovery by CRISPR/Cas9 Knockout.

Authors:  Joshua J Hamey; Beeke Wienert; Kate G R Quinlan; Marc R Wilkins
Journal:  Mol Cell Proteomics       Date:  2017-06-29       Impact factor: 5.911

7.  Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A.

Authors:  Thomas Jank; Yury Belyi; Christophe Wirth; Sabine Rospert; Zehan Hu; Jörn Dengjel; Tina Tzivelekidis; Gregers Rom Andersen; Carola Hunte; Andreas Schlosser; Klaus Aktories
Journal:  J Biol Chem       Date:  2017-08-11       Impact factor: 5.157

8.  Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Authors:  Li Zhong; Giovanna E Hidalgo; Arnold J Stromberg; Nada H Khattar; James R Jett; Edward A Hirschowitz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

9.  Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.

Authors:  Ying Wai Lam; Yong Yuan; Jared Isaac; C V Suresh Babu; Jarek Meller; Shuk-Mei Ho
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

10.  Targeting eEF1A by a Legionella pneumophila effector leads to inhibition of protein synthesis and induction of host stress response.

Authors:  Xihui Shen; Simran Banga; Yancheng Liu; Li Xu; Ping Gao; Ilya Shamovsky; Evgeny Nudler; Zhao-Qing Luo
Journal:  Cell Microbiol       Date:  2009-02-27       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.